Australian-Singaporean regenerative medicine company Osteopore (ASX:OSX) has secured market approvals for its custom orthopaedic and cranial implants in Europe.
Osteopore secures European approval for custom orthopaedic and cranial implants
April 9, 2025 Australian Biotech
Latest Video
New Stories
-
Challenging headlines are the natural consequence of disrupting a very stale debate
April 15, 2025 - - Latest News -
ViiV Healthcare announces the recipients of 2024 Positive Action Community Grants
April 15, 2025 - - Latest News -
US FDA announces plan to phase-out animal testing in drug development
April 15, 2025 - - Latest News -
Medicines Australia appoints new senior policy executive
April 15, 2025 - - Latest News -
This could be a path forward, a move to delay, or both, and we've seen it before
April 14, 2025 - - Latest News -
API launches new B2B e-commerce platform to support its more than 4,000 customers
April 14, 2025 - - Latest News -
Sorry minister, but there's no world in which you kept this election commitment to newborns
April 14, 2025 - - Latest News